Fulgent Genetics (FLGT) Research & Development (2015 - 2026)

Fulgent Genetics has disclosed Research & Development across 12 years of filings, most recently posting $14.2 million for Q1 2026.

• Research & Development for Q1 2026 came in at $14.2 million, up 14.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $55.7 million (up 11.87% YoY), and the FY2025 annual result was $53.9 million, up 10.42% from the prior year.
• Research & Development came in at $14.2 million for Q1 2026 at Fulgent Genetics, roughly flat from $14.2 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $14.2 million in Q1 2026 to a low of $6.0 million in Q1 2022.
• The 5-year median for Research & Development is $11.8 million (2024), against an average of $11.0 million.
• Across the five-year window, Research & Development soared 63.33% in 2023 and decreased 0.04% in 2025, its largest moves.
• Fulgent Genetics' Research & Development stood at $8.5 million in 2022, then soared by 40.46% to $12.0 million in 2023, then climbed by 1.35% to $12.1 million in 2024, then rose by 16.98% to $14.2 million in 2025, then rose by 0.04% to $14.2 million in 2026.
• The last three Research & Development figures came in at $14.2 million (Q1 2026), $14.2 million (Q4 2025), and $13.9 million (Q3 2025), per Business Quant data.